Arming antibodies: prospects and challenges for immunoconjugates
Anna M. Wu(University of California, Irvine), Peter D. Senter(Seagen (United States))
Cited by 1,041
Related Papers
Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug Conjugate
|Clinical Cancer Research|2004|1.2k
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
|Nature Biotechnology|2003|1.2k
cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity
|Blood|2003|918
Antibody–drug conjugates come of age in oncology
|Nature Reviews Drug Discovery|2023|772
Antibody-Drug Conjugates in Cancer Therapy
|Annual Review of Medicine|2012|763